George Tidmarsh named performing head of FDA’s CBER
George Tidmarsh, the Meals and Drug Administration’s prime drug regulator, will tackle further obligations on a short lived foundation after the sudden departure of prime official Vinay Prasad on Tuesday.
Tidmarsh has been named performing director of the FDA’s Heart for Biologics Analysis and Analysis, FDA Commissioner Marty Makary mentioned in an e-mail considered by STAT. That’s one of many roles vacated by Prasad. Prasad was additionally the company’s chief medical and scientific officer.
“The FDA was very lucky to have Vinay’s experience at CBER,” Makary wrote to CBER workers. “He applied main reforms and designed new regulatory frameworks that may have a permanent influence.”
This text is unique to STAT+ subscribers
Unlock this text — plus day by day protection and evaluation of the pharma trade — by subscribing to STAT+.
Have already got an account? Log in
To learn the remainder of this story subscribe to STAT+.
